Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-24

Clinical Trial Update: HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms [NA]

View source ↗

Summary

A Johns Hopkins-led study called HEARS-NPS is investigating whether addressing hearing loss can reduce neuropsychiatric symptoms in Alzheimer’s disease and deme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: Alzheimer Disease, Dementia | NA | Status: RECRUITING